Mouse-trap: brain-only CAR-T cells wipe out deadly kids' tumor in lab tests
UC San Francisco scientists have built an immune cell therapy, called B-SYNC CAR-T, that switches on only after it enters the brain. In two mouse models it completely eliminated diffuse midline glioma, an aggressive childhood brain cancer that is almost always fatal within a year. When researchers reintroduced cancer cells weeks later, the cells kept fighting and prevented new tumors. Conventional CAR-T has struggled against brain tumors, and researchers aren't sure why this approach works better. The work is so far in mice only.
Why it matters: It offers an early sign that CAR-T therapy could be made to work against a nearly always fatal childhood brain cancer, though the results come only from mice and the reason remains unclear.
Comments
No comments yet.